Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 4, 2009, Pages 419.e1-419.e7

  Wright, Jason D ^a,d   Fiorelli, Jessica ^a,d   Kansler, Amanda L ^c   Burke, William M ^a,c,d   Schiff, Peter B ^a,d   Cohen, Carmel J ^b,d   Herzog, Thomas J ^a,d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VALLEY HOSPITAL   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

adjuvant radiotherapy; endometrial cancer; radical hysterectomy; simple hysterectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; THERAPY EFFECT;

EID: 62549128168     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.11.003     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Straughn Jr. J.M., Huh W.K., Kelly F.J., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84 (2002) 194-200
3. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 Suppl 8 (1987) 2035-2041
4. Cohn D.E., Woeste E.M., Cacchio S., et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 109 (2007) 1062-1067
5. Mariani A., Webb M.J., Keeney G.L., Calori G., and Podratz K.C. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol 83 (2001) 72-80
6. Cornelison T.L., Trimble E.L., and Kosary C.L. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol 74 (1999) 350-355
7. Feltmate C.M., Duska L.R., Chang Y., et al. Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol 73 (1999) 407-411
8. Sartori E., Gadducci A., Landoni F., et al. Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11 (2001) 430-437
9. Ayhan A., Taskiran C., Celik C., and Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol 93 (2004) 9-13
10. Trimble E.L., and Jones III H.W. Management of stage II endometrial adenocarcinoma. Obstet Gynecol 71 3 Pt 1 (1988) 323-326
11. Eltabbakh G.H., and Moore A.D. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 74 (1999) 80-85
12. Boente M.P., Orandi Y.A., Yordan E.L., et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2 (1995) 138-144
13. Boente M.P., Yordan Jr. E.L., McIntosh D.G., et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51 (1993) 316-322
14. Calvin D.P., Connell P.P., Rotmensch J., Waggoner S., and Mundt A.J. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol 22 (1999) 338-343
15. Yura Y., Tauchi K., Koshiyama M., et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol 63 (1996) 114-119
16. The Surveillance, Epidemiology, and End Results (SEER) Program, Data Quality (2007), National Cancer Institute. http://seer.cancer.gov/about/ Accessed October 1, 2007
17. Surveillance, Epidemiology, and End Results (SEER) Program, SEER* Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. http://seer.cancer.gov Accessed October 1, 2007
18. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (2004) 744-751
19. Leminen A., Forss M., and Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 74 (1995) 61-66
20. Mannel R.S., Berman M.L., Walker J.L., Manetta A., and DiSaia P.J. Management of endometrial cancer with suspected cervical involvement. Obstet Gynecol 75 (1990) 1016-1022
21. Chen G.D., Lin L.Y., Wang P.H., and Lee H.S. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol 85 (2002) 292-297
22. Abdel-Fattah M., Barrington J., Yousef M., and Mostafa A. Effect of total abdominal hysterectomy on pelvic floor function. Obstet Gynecol Surv 59 (2004) 299-304